Clinical Trials
15 trialsNCT07216443 2026-04-15
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Phase 2 Recruiting
NCT06135415 2026-03-25
TirbAKare
Almirall, S.A.
Phase 3 Completed
NCT04904588 2026-03-18
ACCESS
Center for International Blood and Marrow Transplant Research
Phase 2 Active not recruiting
NCT06001385 2026-02-05
OPTIMIZE
Center for International Blood and Marrow Transplant Research
Phase 2 Active not recruiting
NCT06815939 2026-01-29
OPTICS
DL Analytics
Phase NA Recruiting
NCT03874754 2025-10-14
iHBE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT02158858 2025-10-08
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Phase 1/2 Completed
NCT01837693 2025-06-26
NTCC2
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT04593407 2025-03-13
intERsection
Hospital Universitario 12 de Octubre
Phase NA Recruiting
NCT05636800 2024-08-06
Microwave Treatment for Actinic Keratosis
Blackwell Device Consulting
Phase NA Active not recruiting
NCT00106691 2023-06-12
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
GTx
Phase 3 Completed
NCT03285477 2021-04-13
AK003
Almirall, S.A.
Phase 3 Completed
NCT03285490 2021-03-10
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)
Almirall, S.A.
Phase 3 Completed
NCT00851305 2012-07-17
CLE
Shandong University
Phase NA Completed
NCT00692159 2010-09-10
Study of TRC102 in Combination With Pemetrexed in Cancer Patients
Tracon Pharmaceuticals Inc.
Phase 1 Completed